Skip to main content

Research Repository

Advanced Search

Antacid therapy for gastroesophageal reflux in preterm infants: a systematic review

Dermyshi, Elda; Mackie, Charley; Kigozi, Phoebe; Schoonakker, Bernard; Dorling, Jon

Antacid therapy for gastroesophageal reflux in preterm infants: a systematic review Thumbnail


Authors

Elda Dermyshi

Charley Mackie

Phoebe Kigozi

Bernard Schoonakker

Jon Dorling



Abstract

Background: Gastro-oesophageal reflux is prevalent in preterm infants. Despite widespread use in clinical practice, there is still much controversy over the efficacy and safety of drug interventions, particularly antacid therapy.
Objective: To systematically review the effects of antacid therapy on preterm infants with symptoms of gastro-oesophageal reflux, and to assess the safety of these interventions.
Methods: We carried out an electronic search of the Cochrane central register of controlled trials (CENTRAL, The Cochrane Library), MEDLINE (1966–present), EMBASE (1980–present) and CINAHL (1982–present) as well as other online sources. Participants were preterm infants (<37 weeks gestation) with gastro-oesophageal reflux disease who were receiving care on a neonatal unit. We assessed the effects of histamine-2 receptor antagonists, proton pump inhibitors and alginates against placebo, primarily to see if they reduced the symptoms of reflux.
Results: Six studies were included in this review. Meta-analysis could not be carried out due to a lack of studies assessing the same intervention with the same outcomes. Omeprazole therapy significantly reduced the oesophageal acid exposure percentage time with pH<4 (p<0.01) and sodium alginate significantly decreased gastro-oesophageal reflux episodes (p=0.024). Metoclopramide and ranitidine showed a significant increase in gastro-oesophageal reflux disease symptoms versus placebo (p<0.04). No significant results were found for the use of esomeprazole or lansoprazole versus placebo.
Conclusions: There is insufficient evidence available to conclude whether antacid therapy is effective or safe when treating gastro-oesophageal reflux disease in preterm infants. Further research is needed into this topic and caution should be taken when administering antacids to preterm infants.

Citation

Dermyshi, E., Mackie, C., Kigozi, P., Schoonakker, B., & Dorling, J. (2018). Antacid therapy for gastroesophageal reflux in preterm infants: a systematic review. BMJ Paediatrics Open, 2(1), Article e00028. https://doi.org/10.1136/bmjpo-2018-000287

Journal Article Type Article
Acceptance Date May 14, 2018
Publication Date Jul 9, 2018
Deposit Date Jun 11, 2018
Publicly Available Date Jul 9, 2018
Journal BMJ Paediatrics Open
Electronic ISSN 2399-9772
Publisher BMJ Publishing Group
Peer Reviewed Peer Reviewed
Volume 2
Issue 1
Article Number e00028
DOI https://doi.org/10.1136/bmjpo-2018-000287
Keywords Neonatology; Infant feeding
Public URL https://nottingham-repository.worktribe.com/output/945636
Publisher URL https://bmjpaedsopen.bmj.com/content/2/1/e000287
Contract Date Jun 11, 2018

Files





Downloadable Citations